David Gozal1, Sandra A Ham2, Babak Mokhlesi3. 1. Sections of Pediatric Sleep Medicine and Pulmonology, Department of Pediatrics, Prizkter School of Medicine, Biological Sciences Division, The University of Chicago, Chicago, IL. 2. Center for Health and the Social Sciences, The University of Chicago, Chicago, IL. 3. Sleep Disorders Center and the Section of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Chicago, Chicago, IL.
Abstract
STUDY OBJECTIVES: Epidemiological evidence from relatively small cohorts suggests that obstructive sleep apnea (OSA) is associated with higher cancer incidence and mortality. Here we aimed to determine whether cancer incidence for major cancer types and risk of metastases or mortality from cancer are increased in the presence of OSA. METHODS: All OSA diagnoses included in an employee-sponsored health insurance database spanning the years 2003-2012 were identified and 1:1 matched demographically based on age, gender, and state of residence, or alternatively matched by comorbidities. The incidence of 12 types of cancer was assessed. In addition, another cohort of patients with a primary diagnosis of cancer was retrieved, and the risk of metastatic disease or cancer mortality was determined as a function of the presence or absence of OSA. Multivariate Cox proportional hazards regression models were fitted to assess the independent associations between OSA and outcomes of interest. RESULTS: Based on a cohort of ∼5.6 million individuals, the incidence of all cancer diagnoses combined was similar in OSA and retrospectively matched cases. However, the adjusted risk of pancreatic and kidney cancer and melanoma were significantly higher in patients with OSA, while the risk of colorectal, breast, and prostate cancers appeared to be lower. Among individuals with a diagnosis of cancer, the presence of OSA was not associated with an increased risk for metastasis or death. CONCLUSIONS: In a large nationally representative health insurance database, OSA appears to increase the risk for only a very selective number of cancer types, and does not appear to be associated with an increased risk of metastatic cancer or cancer-related deaths.
STUDY OBJECTIVES: Epidemiological evidence from relatively small cohorts suggests that obstructive sleep apnea (OSA) is associated with higher cancer incidence and mortality. Here we aimed to determine whether cancer incidence for major cancer types and risk of metastases or mortality from cancer are increased in the presence of OSA. METHODS: All OSA diagnoses included in an employee-sponsored health insurance database spanning the years 2003-2012 were identified and 1:1 matched demographically based on age, gender, and state of residence, or alternatively matched by comorbidities. The incidence of 12 types of cancer was assessed. In addition, another cohort of patients with a primary diagnosis of cancer was retrieved, and the risk of metastatic disease or cancer mortality was determined as a function of the presence or absence of OSA. Multivariate Cox proportional hazards regression models were fitted to assess the independent associations between OSA and outcomes of interest. RESULTS: Based on a cohort of ∼5.6 million individuals, the incidence of all cancer diagnoses combined was similar in OSA and retrospectively matched cases. However, the adjusted risk of pancreatic and kidney cancer and melanoma were significantly higher in patients with OSA, while the risk of colorectal, breast, and prostate cancers appeared to be lower. Among individuals with a diagnosis of cancer, the presence of OSA was not associated with an increased risk for metastasis or death. CONCLUSIONS: In a large nationally representative health insurance database, OSA appears to increase the risk for only a very selective number of cancer types, and does not appear to be associated with an increased risk of metastatic cancer or cancer-related deaths.
Authors: Daniel I McIsaac; Andrea Gershon; Duminda Wijeysundera; Gregory L Bryson; Neal Badner; Carl van Walraven Journal: Anesthesiology Date: 2015-08 Impact factor: 7.892
Authors: Francisco Campos-Rodriguez; Miguel A Martinez-Garcia; Montserrat Martinez; Joaquin Duran-Cantolla; Monica de la Peña; María J Masdeu; Monica Gonzalez; Felix del Campo; Inmaculada Gallego; Jose M Marin; Ferran Barbe; Jose M Montserrat; Ramon Farre Journal: Am J Respir Crit Care Med Date: 2012-11-15 Impact factor: 21.405
Authors: Magdalena Olbryt; Anna Habryka; Sebastian Student; Michał Jarząb; Tomasz Tyszkiewicz; Katarzyna Marta Lisowska Journal: PLoS One Date: 2014-08-14 Impact factor: 3.240
Authors: Laura Asnaghi; Michael H Lin; Kah Suan Lim; Kah Jing Lim; Arushi Tripathy; Murilo Wendeborn; Shannath L Merbs; James T Handa; Akrit Sodhi; Eli E Bar; Charles G Eberhart Journal: PLoS One Date: 2014-08-28 Impact factor: 3.240
Authors: Arthur Sillah; Nathaniel F Watson; Stephen M Schwartz; David Gozal; Amanda I Phipps Journal: Cancer Causes Control Date: 2018-08-17 Impact factor: 2.506
Authors: Tianyi Huang; Brian M Lin; Meir J Stampfer; Eva S Schernhammer; Richa Saxena; Shelley S Tworoger; Susan Redline Journal: Sleep Date: 2021-03-12 Impact factor: 5.849